Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of phase I trial

被引：0
|
作者：
Zucali, P. A. [1 ]
Simonelli, M. [1 ]
De Vincenzo, F. [1 ]
Fatuzzo, G. [1 ]
Bertossi, M. [1 ]
Perrino, M. [1 ]
Miggiano, C. [1 ]
Giordano, L. [1 ]
Bonifacio, C. [1 ]
Sposta, F. Mrakic [1 ]
Santoro, A. [1 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H18
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [11] Phase I trial of Pemetrexed, Carboplatin and Sorafenib as first-line treatment in patients with metastatic NSCLC
    Brandts, C.
    Borchard, B.
    Waller, C. F.
    Martens, U. M.
    Kerhoff, A.
    Mohr, M.
    Young, C.
    Gerss, J.
    Serve, H.
    Berdel, W. E.
    Wiewrodt, R.
    ONKOLOGIE, 2010, 33 : 170 - 171
  • [12] Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Botta, M.
    Aitini, E.
    Spigno, F.
    Degiovanni, D.
    Alabiso, O.
    Serra, M.
    Muzio, A.
    Carbone, R.
    Buosi, R.
    Galbusera, V.
    Piccolini, E.
    Giaretto, L.
    Rebella, L.
    Mencoboni, M.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 370 - 373
  • [13] TS, DHFR and GARFT Expression in Non-squamous Cell Carcinoma of NSCLC and Malignant Pleural Mesothelioma Patients Treated with Pemetrexed
    Uramoto, Hidetaka
    Onitsuka, Takamitsu
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    ANTICANCER RESEARCH, 2010, 30 (10) : 4309 - 4315
  • [14] Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
    Hughes, A
    Calvert, P
    Azzabi, A
    Plummer, R
    Johnson, R
    Rusthoven, J
    Griffin, M
    Fishwick, K
    Boddy, AV
    Verrill, M
    Calvert, H
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3533 - 3544
  • [15] PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB PLUS PEMETREXED AND CARBOPLATIN AS FIRST-LINE THERAPY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Ceresoli, Giovanni L.
    Zucali, Paolo A.
    Favaretto, Adolfo G.
    De Vincenzo, Fabio
    Mencoboni, Manlio
    Botta, Mario
    Grossi, Francesco
    Bidoli, Paolo
    Zilembo, N.
    Simonelli, Matteo
    Gianoncelli, Letizia
    Lorenzi, Elena
    Santoro, Armando
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S538 - S539
  • [16] A Phase II Trial of Tiragolumab with Carboplatin, Pemetrexed, And Atezolizumab in Non-Squamous NSCLC and Brain Metastases
    Schluger, B.
    Burns, T. F.
    Wang, H.
    Petro, D. P.
    Ohr, J.
    Burton, S. A.
    McCall, N.
    Choi, S.
    Abdullah, K. G.
    Niranjan, A.
    Hadjipanayis, C. G.
    Villaruz, L. C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S393 - S394
  • [17] Phase I trial of pemetrexed, carboplatin, and sorafenib as first-line treatment in patients with metastatic NSCLC.
    Brandts, C. H.
    Borchard, B.
    Waller, C. F.
    Martens, U. M.
    Mohr, M.
    Young, C.
    Gerss, J.
    Serve, H.
    Berdel, W. E.
    Wiewrodt, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [18] Phase I/II Study of Erlotinib, Carboplatin, Pemetrexed and Bevacizumab for Advanced Non-Squamous NSCLC Harboring EGFR Mutation
    Yokoi, Takashi
    Kurata, Takayasu
    Torii, Yoshitaro
    Satsutani, Naoko
    Kibata, Kayoko
    Niki, Maiko
    Nomura, Shosaku
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1219 - S1219
  • [19] Results of a Phase III Trial of Prolgolimab with Chemotherapy as First-Line Therapy for Patients with Advanced Non-Squamous NSCLC: DOMAJOR
    Laktionov, K.
    Smolin, A.
    Stroyakovsky, D.
    Moiseenko, V.
    Dvorkin, M.
    Andabekov, T.
    Cheng, Y.
    Liu, B.
    Kozlov, V.
    Odintsova, S.
    Dvoretsky, S.
    Mochalova, A.
    Urda, M.
    Yi, T.
    Li, X.
    Laszlo, U.
    Mueler, V.
    Bogos, K.
    Fadeeva, N.
    Musaev, G.
    Liu, Q.
    Kirtbaya, D.
    Shi, J.
    Gladkov, O.
    Narimanov, M.
    Semiglazova, T.
    Khasanova, A.
    Chovanec, J.
    Andrasina, I.
    Szabova, A.
    Rosinska, O.
    Sudekova, D.
    Zsolt, P. S.
    Ran, F.
    Sun, M.
    Jiang, O.
    Chen, R.
    Zhao, E.
    Liu, C.
    Tan, W.
    Pirmagomedov, A.
    Poddubskaya, E.
    Kislov, N.
    Shumskaya, I.
    Zinkina-Orikhan, A.
    Linkova, Y.
    Liaptseva, D.
    Siljutina, A.
    Sorokina, I.
    Kriukov, F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S34 - S35
  • [20] RESTROSPECTIVE COMPARATIVE STUDY OF CARBOPLATIN/PEMETREXED/BEVACIZUMAB AND PEMETREXED/CARBOPLATIN AS FIRST LINE TREATMENT IN PATIENTS WITH ADVANCED NSCLC
    Magallanes, Manuel E.
    Cadena, Angelica C.
    Mendoza, Daniel
    Zincer, Fernando P.
    Bautista, Yolanda L.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S126 - S126
12345